# A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years

> **NCT06592456** · PHASE3 · COMPLETED · sponsor: **Southeast University, China** · enrollment: 1200 (actual)

## Conditions studied

- Chickenpox Vaccines

## Interventions

- **BIOLOGICAL:** Chickenpox Vaccines

## Key facts

- **NCT ID:** NCT06592456
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-21
- **Primary completion:** 2021-10-07
- **Final completion:** 2021-11-08
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592456, "A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06592456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*